Day Trader తెలుగు
13:14 · Feb 6, 2023 · Mon
SUVEN PHARMA: Q3 EBITDA RUPEES 1.47B VS 1.86B (YOY) || Q3 EBITDA MARGIN 41.47% VS 47.5% (YOY)
POOR EBITDA
POOR MARGINS
Please enable JavaScript to view the
comments powered by Disqus.
Home